Goserelin
Based on 2 publication(s) in Google Scholar
Goserelin (ICI 118630), a decapeptide analogue of gonadotropin-releasing hormone (GnRH/LHRH), functions as a GnRH agonist. Goserelin can be used for the research of breast cancer, epithelial ovarian cancer and prostate cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 65807-02-5
- Formule: C59H84N18O14
- Masse moléculaire:1269.41
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Goserelin
More
Activité biologique
GnRH[1]
Goserelin (1 nM-1 mM; 48-72 hours) promots EOC cell apoptosis[1].
Goserelin (100 μM; 24-72 hours) regulates the expression of human apoptosis-related genes in SKOV3-ip cells[1].
Goserelin (100 μM; 24-72 hours) influences EOC cell apoptosis by upregulating FOXO1 through the PI3K/AKT signaling pathway[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:SKOV3 cells, SKOV3-ip cells, A2780 cells (human EOC cell lines)
-
Concentration:1 nM, 10 nM, 100 nM, 1 μM, 10 μM, 100 μM, 1 mM
-
Incubation Time:48 hours, 72 hours
-
Result:Significantly increased the total apoptosis rate of SKOV3-ip, SKOV3 and A2780 cells.
-
Cell Line:SKOV3 cells, SKOV3-ip cells, A2780 cells (human EOC cell lines)
-
Concentration:1 nM, 10 nM, 100 nM, 1μM , 10 μM, 100 μM, 1 mM
-
Incubation Time:48 hours, 72 hours
-
Result:The expression of cleaved-caspase-3 and cleaved-PARP were observably increased at 100 μM.
-
Cell Line:SKOV3-ip cells
-
Concentration:100 μM
-
Incubation Time:24 hours, 48 hours, 72 hours
-
Result:Expression of human apoptosis-related genes regulated
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Five-week-old specific-pathogen free (SPF) female nude mice (18-20 g), subcutaneous xenograft tumor model[1]
-
Dosage:100 µg/mice
-
Administration:Subcutaneous injection, daily, for 19 days
-
Result:Significantly increased the proportion of apoptotic cells in the subcutaneous xenograft tumors
Chemical Information
-
CAS No. 65807-02-5
-
Masse moléculaire 1269.41
-
Formule C59H84N18O14
-
Synonyms
ICI 118630
-
Sequence
{Glp}-His-Trp-Ser-Tyr-Ser(OtBu)-Leu-Arg-Pro-{Hydrazinecarboxamide}
-
Sequence Shortening
{Glp}-HWSY-Ser(OtBu)-LRP-{Hydrazinecarboxamide}
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Environ Sci Technol
A Novel Screening Framework Integrating a Two-Cell Assay System and Computational Toxicology to Identify Disruptors of the GnRH Neuron-Gonadotrope Axis. [Abstract]2026 Apr 7;60(13):9881-9894. PMID: 41872703 -
Commun Biol
Diurnal testosterone oscillations gate drug delivery via phase separation of ZO-1 at the blood-testis barrier in mice. [Abstract]2026 Jun 1. PMID: 42219451
Pureté et documentation
Références
[1]. Ning Zhang, et al. Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway. Oncol Rep. 2018 Mar; 39(3): 1034–1042. [Content Brief]
[2]. Halle C F Moore, et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med. 2015 Mar 5;372(10):923-32. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)